CSIMarket
 


Biomea Fusion Inc   (BMEA)
Other Ticker:  
 
 

BMEA's Capital Expenditures Growth by Quarter and Year

Biomea Fusion Inc 's Capital Expenditures results by quarter and year




BMEA Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.71 0.29 0.00
III Quarter September 0.04 0.00 2.04 0.00
II Quarter June 0.42 0.27 0.77 0.00
I Quarter March 2.91 0.10 0.07 0.00
FY   3.37 1.08 3.17 0.00



BMEA Capital Expenditures third quarter 2023 Y/Y Growth Comment
Biomea Fusion Inc in the third quarter 2023 achieved Capital Expenditures of $ 0.04 millions compare to Capital Expenditures recorded in same quarter a year ago.

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 218 other companies have achieved higher Capital Expenditures growth. While Biomea Fusion Inc ' s Capital Expenditures no change of % ranks overall at the positon no. 3315 in the third quarter 2023.




BMEA Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 144.83 % - -
III Quarter September - - - -
II Quarter June 55.56 % -64.94 % - -
I Quarter March 2810 % 42.86 % - -
FY   - -65.93 % - -

Financial Statements
Biomea Fusion Inc 's third quarter 2023 Capital Expenditures $ 0.04 millions BMEA's Income Statement
Biomea Fusion Inc 's third quarter 2022 Capital Expenditures $ 0.00 millions Quarterly BMEA's Income Statement
New: More BMEA's historic Capital Expenditures Growth >>


BMEA Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - -85.78 % -
III Quarter September -90.71 % - 164.94 % -
II Quarter June -85.57 % 170 % 1000 % -
I Quarter March 309.86 % -65.52 % - -
FY (Year on Year)   - -65.93 % - -




Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #219
Healthcare Sector #586
Overall #3315

Capital Expenditures Y/Y Growth Statistics
High Average Low
1050.75 % 142.37 % -100 %
(Jun 30 2021)   (Sep 30 2022)
Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #219
Healthcare Sector #586
Overall #3315
Capital Expenditures Y/Y Growth Statistics
High Average Low
1050.75 % 142.37 % -100 %
(Jun 30 2021)   (Sep 30 2022)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Biomea Fusion Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
1050.75 % 142.37 % -100 %
(Jun 30 2021)  


BMEA's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2023 Biomea Fusion Inc realized fall in Capital Expenditures from the second quarter by -90.71% to $ 0.04 millions, from $ 0.42 millions declared a quarter before.

Within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Biomea Fusion Inc 's Capital Expenditures growth quarter on quarter, overall rank is 452.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #38
Overall #452
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #38
Overall #452
Capital Expenditures Q/Q Growth Statistics
High Average Low
1050.75 % 142.37 % -100 %
(Jun 30 2021)  


BMEA's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2023 Biomea Fusion Inc disclosed fall in Capital Expenditures from the second quarter by -90.71% to $ 0.04 millions, from $ 0.42 millions declared a quarter before.

Within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Biomea Fusion Inc 's Capital Expenditures growth quarter on quarter, overall rank is 452.


Biomea Fusion Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 4.07 $ 0.00 $ 0.00 $ 0.00 $ 0.61
Y / Y Capital Expenditures Growth (TTM) - - - - -89.9 %
Year on Year Capital Expenditures Growth Overall Ranking # 369 # 379 # 1869 # 2425 # 2469
Seqeuential Capital Expenditures Change (TTM) - - - - -77.38 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 366 # 311 # 1186 # 2192 # 2149




Cumulative Capital Expenditures growth Comment


Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 369, from total ranking in previous quarter at 379.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
-89.9 %
-89.9 %
-89.9 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 35
Overall # 369

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
-89.9 %
-89.9 %
-89.9 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 35
S&P 500 # 366
Cumulative Capital Expenditures growth Comment


Within the Healthcare sector 34 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 369, from total ranking in previous quarter at 379.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
-89.9 %
-89.9 %
-89.9 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 35
Overall # 369

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
-89.9 %
-89.9 %
-89.9 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 35
S&P 500 # 366




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
BMEA's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for BMEA's Competitors
Capital Expenditures Growth for Biomea Fusion Inc 's Suppliers
Capital Expenditures Growth for BMEA's Customers

You may also want to know
BMEA's Annual Growth Rates BMEA's Profitability Ratios BMEA's Asset Turnover Ratio BMEA's Dividend Growth
BMEA's Roe BMEA's Valuation Ratios BMEA's Financial Strength Ratios BMEA's Dividend Payout Ratio
BMEA's Roa BMEA's Inventory Turnover Ratio BMEA's Growth Rates BMEA's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Encompass Health Corporation-0.54%$ -0.542 millions
Myriad Genetics Inc -1.13%$ -1.130 millions
Opgen inc -1.22%$ -1.220 millions
Avantor Inc -3.33%$ -3.333 millions
United Therapeutics Corporation-4.51%$ -4.506 millions
Enanta Pharmaceuticals Inc-4.80%$ -4.802 millions
Davita Inc -5.46%$ -5.463 millions
Science 37 Holdings Inc -5.63%$ -5.630 millions
Cutera Inc -5.71%$ -5.708 millions
Zoetis Inc -5.84%$ -5.844 millions
U S Physical Therapy Inc-6.25%$ -6.248 millions
Generation Bio Co -6.30%$ -6.298 millions
Ngm Biopharmaceuticals Inc -6.45%$ -6.452 millions
Becton Dickinson And Company-6.67%$ -6.667 millions
3m Company-6.90%$ -6.897 millions
Apyx Medical Corporation-7.45%$ -7.447 millions
Edwards Lifesciences Corporation-7.68%$ -7.679 millions
Viatris Inc -7.70%$ -7.700 millions
Luna Innovations Inc-8.23%$ -8.232 millions
Nevro Corp -8.38%$ -8.377 millions
Shockwave Medical Inc -8.65%$ -8.649 millions
Sonendo Inc -8.86%$ -8.861 millions
Charles River Laboratories International inc -8.90%$ -8.904 millions
Nautilus Biotechnology Inc -9.24%$ -9.242 millions
Harvard Bioscience Inc-9.28%$ -9.276 millions
Fulgent Genetics Inc -9.42%$ -9.420 millions
Idexx Laboratories Inc-9.53%$ -9.529 millions
Sage Therapeutics Inc -9.89%$ -9.890 millions
Caredx Inc -10.40%$ -10.400 millions
Quest Diagnostics Inc-11.02%$ -11.017 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com